Power of Providers Webinars

Upcoming Peer-to-Peer Webinars


 

Effectively Engaging Communities Series: Building Relationships and Establishing Trust

Date: April 19, 2024
Time: Noon to 1 p.m. Pacific Time

Dr. Michelle Andrasik will present historical and contemporary factors associated with increased mistrust and distrust among priority communities and present effective methods for engaging with communities to identify strategies to create safe, welcoming, and affirming spaces. 

The webinar will be recorded and continuing education credits for nurses and medical assistants are available.


Effectively Engaging Communities Series: Addressing Vaccine Hesitancy

Date: May 10, 2024
Time: Noon to 1 p.m. Pacific Time

Dr. Michelle Andrasik will cover the factors that fuel vaccine hesitancy and effective strategies to address it, including patient-centered approaches and trusted messenger interventions.

The webinar will be recorded and continuing education credits for nurses and medical assistants are available.


Past Webinars

Continuing Education Credits Available

Unmasking Long COVID: Insights and Updates from University of Washington Clinical Research

This webinar occurred on March 29, 2024, and continuing education credit expires on June 29, 2024.

Evaluation Survey 
Video Recording (YouTube)
Webinar Slides (PDF)

 

Disclosure Declaration

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers, and planners) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.

Faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. The speakers, course director, and planners at the Federation of State Medical Boards, have nothing to disclose.

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

No speaker or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

• Describe specific research projects and studies conducted by the University of Washington related to Long COVID.

• Illustrate the role of University of Washington in advancing the understanding of Long COVID, including key findings and contributions to the field.

• Describe ongoing efforts and future directions in Long COVID research, including future potential improved diagnostics and therapies.

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

Speaker Biography

Dr. Chu is a Professor of Medicine at the University of Washington. She earned her M.D. at Duke and her M.P.H. at the UW. Dr. Chu’s research focus is on preventive interventions against influenza, RSV and emerging respiratory viruses, including SARS-CoV-2. She conducts clinical-translational research on large-scale community-based studies of respiratory viruses, with a focus on vaccines, antivirals, and diagnostics and was a Multiple Principal Investigator of the Seattle Flu Study, which first identified COVID-19 community transmission in the United States. She is also interested in defining clinical and immune correlates of protection against respiratory viruses and describing mechanisms of maternal-fetal immunity against respiratory viruses.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Pam Kohlmeier, MD, JD, FACEP
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.

Continuing Education

There is no charge for continuing education credit. Continuing education is available for physicians (MD, ND, DO), physician assistants, nurses (RN, LPN, ARNP), and medical assistants attending live or watching the recording.  After watching the recording, please complete the evaluation survey. The survey must be completed to earn CE credit.  When attending live or watching the recording as a group, everyone MUST register for the webinar and complete the evaluation as an individual prior to receiving credit. Around 6/29/2024, we will email certificates to those who have watched the recording and completed the evaluation survey.

 

Post COVID-19 Conditions: Expanding Our Understanding of Long-term Sequelae of COVID-19

This webinar occurred on February 16, 2024, and continuing education credit expires on May 16, 2024.

Continuing Education

  • There is no charge for continuing education credit.
  • Continuing education is available for physicians (MD, ND, DO), physician assistants, nurses (RN, LPN, ARNP), and medical assistants attending live or watching the recording. 
  • After watching the recording, please complete the evaluation survey. The survey must be completed to earn CE credit. 
  • When attending live or watching the recording as a group, everyone MUST register for the webinar and complete the evaluation as an individual prior to receiving credit.
  • Around 5/16/2024, we will email certificates to those who have watched the recording and completed the evaluation survey.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

Summarize the terms and case definitions associated with post-COVID-19 conditions.

  • Recognize the clinical features commonly associated with certain phenotypes of post-COVID-19 conditions.
  • Describe the known epidemiology and factors associated with the development of post-COVID-19 conditions.
  • Describe the possible etiologies and underlying pathophysiologic explanations for post-COVID-19 conditions.

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

Speaker Biography

Eric J. Chow, MD, MS, MPH is the Chief of Communicable Disease Epidemiology and Immunization for Public Health – Seattle & King County and is a Clinical Assistant Professor in the Division of Allergy and Infectious Diseases and in the Department of Epidemiology. Dr. Chow received his MD and MPH from Eastern Virginia Medical School. He completed his residency training in combined internal medicine and pediatrics at Brown University/Rhode Island Hospital where he also completed a pediatric chief residency.

From 2018-2020, he was an Epidemic Intelligence Service (EIS) Officer within the Influenza Division where he worked on division level priorities and on field investigations including influenza, measles, Ebola and SARS-CoV-2. He supported Public Health – Seattle & King County’s response to the long-term care facility COVID-19 outbreak and helped characterize the initial cases of multi-system inflammatory syndrome in children in the United States. He completed an adult infectious disease fellowship at the University of Washington. His peer reviewed publications and research interests focus on community respiratory virus epidemiology, extra-pulmonary manifestations of respiratory viruses and emerging infectious diseases.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Pam Kohlmeier, MD, JD, FACEP
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.

Disclosure Declaration

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers, and planners) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
Faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. The speakers, course director, and planners at the Federation of State Medical Boards, have nothing to disclose.

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

No speaker or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.

Post COVID-19 Conditions: Diagnosis and Management Options

This webinar occurred on January 12, 2024, and continuing education credit expires on April 12, 2024.

Continuing Education

  • There is no charge for continuing education credit.
  • Continuing education is available for physicians (MD, ND, DO), physician assistants, nurses (RN, LPN, ARNP), and medical assistants attending live or watching the recording. 
  • After watching the recording, please complete the evaluation survey. The survey must be completed to earn CE credit. 
  • When attending live or watching the recording as a group, everyone MUST register for the webinar and complete the evaluation as an individual prior to receiving credit.
  • Around 4/12/2024, we will email certificates to those who have watched the recording and completed the evaluation survey.

Learning Objectives

  • By reviewing the most common clinical presentations, patterns and their pathophysiology, participants will be able to recognize clinical presentations of Post-COVID-19 conditions.
  • Participants will be able to describe the diagnostic techniques most commonly utilized to diagnose Post-COVID-19 conditions.
  • Participants will be able to identify available treatment management options for Post-COVID-19 conditions, including integrative medicine options.
  • Participants will be able to identify and illustrate ongoing research and treatment management options on the horizon.

Target Audience

Health care providers, public health staff, and anyone interested in learning more about this topic.

Presenters

  • Anita Chopra, MD practices internal medicine with a focus on geriatrics at UW Medicine Shoreline. She is Chair of the American College of Physicians’ (ACP) Primary Care Council and Co-Chair of the ACP International Medical Graduate Council.
  • Janna Friedly, MD, MPH is a professor and Vice Chair of Clinical Affairs in Rehabilitation Medicine at the University of Washington. Dr. Friedly also serves as Executive Director of Harborview Medical Center’s Outpatient Rehabilitation Clinic.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Pam Kohlmeier, MD, JD, FACEP
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.

Disclosure Declaration

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers, and planners) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.

Faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. The speakers, course director, and planners at the Federation of State Medical Boards, have nothing to disclose.

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

No speaker or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.

Non-Credit Webinar Recordings

Behavioral Health Support for Health Care Workers Series
Long COVID Webinars
Other Topics